Associated Papers
Expressions of Cushing's syndrome in multiple endocrine neoplasia type 1.
Simonds WF
Frontiers in Endocrinology, 2023
Clinical aspects of multiple endocrine neoplasia type 1.
Al-Salameh A et al.
Nature Reviews. Endocrinology, 2021
The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group.
van den Broek MFM et al.
The Journal of Clinical Endocrinology and Metabolism, 2021
Comprehensive Analysis of MEN1 Mutations and Their Role in Cancer.
Nelakurti DD et al.
Cancers, 2020
Children with MEN1 gene mutations may present first (and at a young age) with Cushing disease.
Makri A et al.
Clinical Endocrinology, 2018
Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.
Gleeson FC et al.
Oncotarget, 2017
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS et al.
Cancer, 2016
EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
van Asselt SJ et al.
Gastrointestinal Endoscopy, 2015
Achieving high-sensitivity for clinical applications using augmented exome sequencing.
Patwardhan A et al.
Genome Medicine, 2015
26269718 (PubMed )
Supplement: 13073_2015_197_MOESM8_ESM.xlsx › Sheet1
Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding.
Roijers JF et al.
European Journal of Clinical Investigation, 2000
Select a paper to view details